{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:36:44Z","timestamp":1760834204412,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.trim.2020.101318","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:25:32Z","timestamp":1593725132000},"page":"101318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of HLA polymorphisms among cadaveric donors on kidney graft allocation"],"prefix":"10.1016","volume":"62","author":[{"given":"Zorana","family":"Grubic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Burek Kamenaric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julijana","family":"Kljajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Stingl Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Maskalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Zunec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trim.2020.101318_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/kidney disease outcomes quality initiative (NKF\/KDOQITM) conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2020.101318_bb0010","first-page":"2002","article-title":"End-stage renal disease","volume":"2010","author":"Abbasi","year":"2010","journal-title":"BMJ Clin. Evid."},{"issue":"6","key":"10.1016\/j.trim.2020.101318_bb0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ndt\/gfv289","article-title":"Defining end-stage renal disease in clinical trials: a framework for adjudication","volume":"31","author":"Agarwal","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2020.101318_bb0020","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1681\/ASN.2006090952","article-title":"Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: reasons for geographic and racial differences in stroke (REGARDS) renal cohort study","volume":"18","author":"McClellan","year":"2007","journal-title":"JASN."},{"issue":"9","key":"10.1016\/j.trim.2020.101318_bb0025","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/dc19-0315","article-title":"Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes","volume":"42","author":"Winkler","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trim.2020.101318_bb0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humimm.2013.04.016","article-title":"Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population","volume":"74","author":"Vuong","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2020.101318_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12882-015-0165-7","article-title":"Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study","volume":"16","author":"Dai","year":"2015","journal-title":"BMC Nephrol."},{"issue":"7653","key":"10.1016\/j.trim.2020.101318_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature22329","article-title":"Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells","volume":"545","author":"Ooi","year":"2017","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.trim.2020.101318_bb0045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1034\/j.1399-0039.2001.057004344.x","article-title":"Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure","volume":"57","author":"Doxiadis","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.trim.2020.101318_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trim.2018.02.001","article-title":"The prevalence of HLA alleles in a lupus nephritis population","volume":"47","author":"de Holanda","year":"2018","journal-title":"Transpl. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2020.101318_bb0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.trim.2020.101318_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111403","article-title":"HLA class I and class II associations with ESRD in Saudi Arabian population","volume":"9","author":"Hamdi","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.trim.2020.101318_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/09723757.2004.11885885","article-title":"HLA - antigene and haplotype frequency in renal transplant recipients and donors of Maharashtra (Western India)","volume":"4","author":"Prasanavar","year":"2004","journal-title":"Int. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.trim.2020.101318_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/TP.0b013e3181c90287","article-title":"Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: an evidence base for a new national kidney allocation policy","volume":"89","author":"Johnson","year":"2010","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2020.101318_bb0075","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/00007890-199811150-00007","article-title":"The new Eurotransplant kidney allocation system: report one year after implementation","volume":"66","author":"De Meester","year":"1998","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2020.101318_bb0080","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.humimm.2009.04.010","article-title":"Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant","volume":"70","author":"Claas","year":"2009","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2020.101318_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.transproceed.2014.12.018","article-title":"A new HLA allocation procedure of kidneys from deceased donors in the current era of immunosuppression","volume":"47","author":"Broeders","year":"2015","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2020.101318_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-59745-223-6_5","article-title":"HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of the LuminexTM technology","volume":"134","author":"Dalva","year":"2007","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.trim.2020.101318_bb0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","article-title":"HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours","volume":"39","author":"Olerup","year":"1992","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.trim.2020.101318_bb0110","first-page":"514","article-title":"PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data","author":"Lancaster","year":"2003","journal-title":"Pac. Symp. Biocomput."},{"issue":"6","key":"10.1016\/j.trim.2020.101318_bb0115","article-title":"HLA polymorphism and susceptibility to end-stage renal disease in Cantonese patients awaiting kidney transplantation","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.trim.2020.101318_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/tan.13305","article-title":"Autoimmune diseases and 8.1 ancestral haplotype: an update","volume":"92","author":"Gambino","year":"2018","journal-title":"HLA."},{"issue":"2","key":"10.1016\/j.trim.2020.101318_bb0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.177.2.557","article-title":"An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles","volume":"177","author":"Wilson","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trim.2020.101318_bb0130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0198-8859(01)00264-6","article-title":"A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity","volume":"62","author":"Lio","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2020.101318_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198101223040401","article-title":"Defective fc-receptor functions associated with the HLA-B8\/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects","volume":"304","author":"Lawley","year":"1981","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.trim.2020.101318_bb0140","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3109\/0886022X.2014.937672","article-title":"Association between human leukocyte antigens (HLA-A, -B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation","volume":"36","author":"Mosaad","year":"2014","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.trim.2020.101318_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2370.2000.00193.x","article-title":"Polymorphism of HLA-A, -B, -DRB1, \u2212DQA1 and -DQB1 haplotypes in a Croatian population","volume":"27","author":"Grubi\u0107","year":"2000","journal-title":"Eur. J. Immunogenet."},{"issue":"3","key":"10.1016\/j.trim.2020.101318_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/iji.12117","article-title":"HLA-A, HLA-B and HLA-DRB1 allele and haplotype diversity among volunteer bone marrow donors from Croatia","volume":"41","author":"Grubic","year":"2014","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.trim.2020.101318_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2014.12.004","article-title":"Immunogenetics of type 1 diabetes mellitus","volume":"42","author":"Morran","year":"2015","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.trim.2020.101318_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trim.2018.02.001","article-title":"The prevalence of HLA alleles in a lupus nephritis population","volume":"47","author":"de Holanda","year":"2018","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2020.101318_bb0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fimmu.2012.00111","article-title":"Compatibility and kidney transplantation: the way to go","volume":"3","author":"Doxiadis","year":"2012","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2020.101318_bb0170","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.transproceed.2008.02.086","article-title":"HLA polymorphisms as incidence factor in the progression to end-stage renal disease in Brazilian patients awaiting kidney transplant","volume":"40","author":"Crispim","year":"2008","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.trim.2020.101318_bb0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0272-6386(12)80132-6","article-title":"HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern organ procurement foundation","volume":"23","author":"Freedman","year":"1994","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.trim.2020.101318_bb0180","first-page":"37","article-title":"HLA class I association with progression to end-stage renal disease in patients from Zulia","volume":"31","author":"Rivera","year":"2012","journal-title":"Venezuela. Imunol."},{"key":"10.1016\/j.trim.2020.101318_bb0185","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"28","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucleic Acid Res."},{"issue":"4","key":"10.1016\/j.trim.2020.101318_bb0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.TP.0000103725.72023.D7","article-title":"It takes six to boogie: allocating cadaver kidneys in Eurotransplant","volume":"77","author":"Doxiadis","year":"2004","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2020.101318_bb0195","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/01.tp.0000261108.27421.bc","article-title":"Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility","volume":"83","author":"Doxiadis","year":"2007","journal-title":"Transplantation"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327420300885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327420300885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:59:32Z","timestamp":1760810372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327420300885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":37,"alternative-id":["S0966327420300885"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2020.101318","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of HLA polymorphisms among cadaveric donors on kidney graft allocation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2020.101318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101318"}}